MDWD – mediwound ltd. - ordinary shares (US:NASDAQ)

News

Newly Published U.S. Expert Consensus Aligns with MediWound’s Strategy for Chronic Wound Debridement
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million
MediWound Q4 Earnings Call Highlights [Yahoo! Finance]
MediWound outlines $24M–$26M 2026 revenue target while expanding EscharEx clinical programs [Seeking Alpha]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com